We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · August 05, 2020

Accuracy of Plasma Phospho-tau217 for Discriminating Alzheimer's Disease From Other Neurodegenerative Disorders

JAMA: The Journal of the American Medical Association


Additional Info

JAMA: The Journal of the American Medical Association
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
JAMA 2020 Jul 28;[EPub Ahead of Print], S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, Y Su, Y Chen, GE Serrano, A Leuzy, N Mattsson-Carlgren, O Strandberg, R Smith, A Villegas, D Sepulveda-Falla, X Chai, NK Proctor, TG Beach, K Blennow, JL Dage, EM Reiman, O Hansson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading